Another publication that may have confused the issue was an early report on fallopian tube and peritoneal cancers that suggested risks of only 0.6% and 1.3%, respectively, based on identification of BRCA1/2 in 5/29 (17.2%) and 9/22 (40%) of primary‐site tumours analysed.31 This evidence concerns the gene BRCA1 and neoplasm.